bioaccess® is a top contract research organization (CRO) in Latin America. It focuses on offering high-quality clinical research services for the medical technology (Medtech) sector. The primary purpose of bioaccess® is to facilitate the rapid advancement of medical devices from pilot studies to commercialization. They aim to support Medtech startups by offering cost-effective, high-quality clinical research services that accelerate clinical study. The team has more than 20 years of experience in Medtech. This gives them a strong understanding of the industry and its rules.
bioaccess LATAM CRO Experts
Newsletter
Get the Global Trial Accelerators™ newsletter
Practical insights on first-in-human and early feasibility trials across medtech, biotech/biopharma and radiopharma, in your inbox.
Free. Unsubscribe anytime. See the bioaccess® Privacy Policy (opens in a new tab) and the newsletter platform's Terms of Service (opens in a new tab).
Recent Episodes
- Varun Kalaiarasan, PhD Researcher at University of Cincinnati
- Ryan Beal, Chief Executive Officer at Dyve Biosciences
- Sandi Schaible, Founder & President at Bonded in Science
- Gennaro Maida, CEO and Founder at Denovo Innovations Group
- Benjamin Holmes, Chief Executive Officer at Nanochon
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- See all →